HealthQuad closes second fund, raised Rs 1215 crores, led by global pharma giant MSD MD Bureau31 March 2022 5:32 PM ISTHealthQuad, India's leading healthcare venture capital fund, has announced the final close of its second fund, HealthQuad Fund-II, with a total...
Ondexxya approved in Japan for treating uncontrolled bleeding MD Bureau31 March 2022 4:59 PM ISTOndexxya has been approved in Japan for patients treated with the Factor Xa (FXa) inhibitors apixaban, rivaroxaban or edoxaban, when reversal of...
BioNTech to expand clinical trial programme for more anti-Omicron vaccine options MD Bureau31 March 2022 4:53 PM ISTBioNTech said on Wednesday it would expand an ongoing clinical trial programme to develop new vaccines and patterns of administration for better...
Qure.ai gets Rs 300 crore from Novo Holdings and HealthQuad to expand market MD Bureau31 March 2022 12:06 PM ISTQure AI announced that we have secured $40 million in a funding round led by Novo Holdings and HealthQuad, supported by existing investor Mass Mutual...
Sun Pharma to market its own version of Vortioxetine, signs agreement with Lundbeck MD Bureau31 March 2022 12:02 PM ISTVortioxetine is a novel antidepressant with multimodal activity, which is approved to treat Major Depressive Disorder in adults.
UK study to test Pfizer COVID drug Paxlovid in hospitalised patients Ruchika Sharma31 March 2022 9:45 AM ISTRecovery, led by the University of Oxford, will probe whether Paxlovid shortens the length of hospital stay or reduces the need for a mechanical...
Daiichi Sankyo gets Japenese nod for Tarlige tablets to treat neuropathic pain Ruchika Sharma31 March 2022 9:45 AM ISTTokyo: Daiichi Sankyo Company, Limited has announced that the company has obtained approval in Japan to change the indication of the analgesic...
Digital health firm Altibbi raises Rs 334 crore in series B round Ruchika Sharma31 March 2022 9:30 AM ISTDubai: Altibbi, a Middle East digital health platform founded in Jordan and headquartered in Dubai, has raised $44 million in a series B round to...
Strides: Dr R Ananthanarayanan to depart as MD, Arun Kumar to take charge Ruchika Sharma30 March 2022 4:33 PM ISTBengaluru: Strides Pharma Science Limited, a global pharmaceutical company, has announced that Dr. R. Ananthanarayanan(Ananth) has decided to depart ...
Manufacturing of 35 APIs started in India under PLI scheme, says Govt Ruchika Sharma30 March 2022 2:26 PM ISTSelf manufacturing would lead to reduction in import dependence of the key raw materials used for producing medicines, Mandaviya added.
Govt fixes trade margins of over 40 costly cancer drugs Ruchika Sharma30 March 2022 1:12 PM ISTThe minister informed the House that the MRPs of these cancer medicines have been capped in such a manner that it cannot be more than 60 percent of...
Pfizer gets expanded USFDA emergency use nod for additional COVID Vaccine booster in adults aged 50 years and older Ruchika Sharma30 March 2022 12:25 PM ISTThe additional booster is to be administered at least four months after the first booster and is the same formulation and strength as prior...
